Positive Alzheimer's Treatment Results Announced By This Health Company

Alzheimer’s Breakthrough: Longeveron Announces Positive Results from Lomecel-B™ Treatment Trials.

The medical world has recently been stirred by promising news in the fight against Alzheimer's disease. Longeveron Inc., a leading biotherapeutics company, has revealed additional positive clinical data and imaging biomarker results from their Phase 2a CLEAR MIND trial of Lomecel-B™. This breakthrough could potentially revolutionize the treatment approa…